BENETOR PLUS 20mg/12.5mg and 20mg/25mg film-coated tablets

  • Name:

    BENETOR PLUS 20mg/12.5mg and 20mg/25mg film-coated tablets

  • Company:
    info
  • Active Ingredients:

    Hydrochlorothiazide, olmesartan medoxomil

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 09/06/20

files-icon(Click to Download)
Summary of Product Characteristics last updated on medicines.ie: 9/6/2020

Click on this link to Download PDF directly

Daiichi Sankyo Ireland Ltd

Daiichi Sankyo Ireland Ltd

Company Products

Medicine NameActive Ingredients
Medicine Name BENETOR 10mg, 20 mg and 40 mg film-coated tablets Active Ingredients olmesartan medoxomil
Medicine Name BENETOR PLUS 20mg/12.5mg and 20mg/25mg film-coated tablets Active Ingredients Hydrochlorothiazide, olmesartan medoxomil
Medicine Name Efient 5mg & 10mg film-coated tablets (Eli Lilly and Company Ltd Daiichi Sankyo UK Ltd) Active Ingredients prasugrel hydrochloride
Medicine Name Evista Active Ingredients Raloxifene
Medicine Name Lixiana Film-Coated Tablets Active Ingredients Edoxaban tosilate
1 - 0 of 5 items.Total: Infinity pages

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 9 June 2020

Reasons for updating

  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.8 - Undesirable effects

Free text change information supplied by the pharmaceutical company

Updated following Type IA Choroidal Effusion

Updated on 9 June 2020 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Free text change information supplied by the pharmaceutical company

Updated for Type IA Choroidal Effusion

Updated on 23 November 2018 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects

Updated on 22 November 2018

Reasons for updating

  • New SmPC for new product

Updated on 23 December 2016 PIL

Reasons for updating

  • New PIL for new product

Updated on 23 December 2016 PIL

Reasons for updating

  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
  • Change to section 6 - date of revision

Updated on 22 July 2016 PIL

Reasons for updating

  • Change to storage instructions
  • Change to date of revision

Updated on 5 February 2015 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to drug interactions

Updated on 17 November 2014 PIL

Reasons for updating

  • Change to warnings or special precautions for use

Updated on 11 November 2014 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Addition of information on reporting a side effect.

Updated on 28 July 2014 PIL

Reasons for updating

  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
  • Change to further information section

Updated on 21 December 2011 PIL

Reasons for updating

  • Change due to harmonisation of PIL

Updated on 11 October 2011 PIL

Reasons for updating

  • Improved electronic presentation

Updated on 21 April 2010 PIL

Reasons for updating

  • Change of contraindications
  • Change to side-effects
  • Change to information about pregnancy or lactation
  • Change to marketing authorisation holder

Updated on 26 September 2006 PIL

Reasons for updating

  • Improved electronic presentation

Updated on 6 September 2006 PIL

Reasons for updating

  • Correction of spelling/typing errors

Updated on 4 September 2006 PIL

Reasons for updating

  • New PIL for new product